InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Faeth Therapeutics, Inc.

FTH Clue Score45
United States Fiscal year ends December CIK 0001829802 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
James Peyer
9 Dec 2025
10% owner
Sold after exercise indirect
446
$7.92
$3.53K
James Peyer
9 Dec 2025
10% owner
Sold after exercise indirect
395
$8.04
$3.18K
James Peyer
9 Dec 2025
10% owner
Sold after exercise indirect
2,666
$7.95
$21.19K
Cambrian BioPharma Inc
9 Dec 2025
10% owner
Sold after exercise
446
$7.92
$3.53K
Cambrian BioPharma Inc
9 Dec 2025
10% owner
Sold after exercise
395
$8.04
$3.18K
Cambrian BioPharma Inc
9 Dec 2025
10% owner
Sold after exercise
2,666
$7.95
$21.19K
Cambrian BioPharma Inc
9 Dec 2025
10% owner
Sold after exercise
3,105
$8.59
$26.67K
Show all 229 transactions →

What was left out

Form 4 filings counted 199
Amendments (4/A) skipped 13
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 14,183,920
Sales filed before the plan box existed 4
History held since 5 Feb 2021